Roundtable Session – What Have We Learnt from AACR?

Time: 3:00 pm
day: Day One Track F


Following an array of data updates from RAS-mutant therapies at AACR, it is important that we take time to

reflect, digest and consider how this information can be used to guide our next steps. Leading professors will navigate us through what we know, and lead the conversation as we consider the future of RAS targeted therapies